Section of Nephrology
Associate Professor of Medicine
Director, Woodlawn Dialysis facility
Referring Physician Access Line: 1-877-DOM-2730
|BS||1981||Winona State University||Nursing
|MD||1988||Texas College of Osteopathic Hospital||
|Residency||1992||Loyola University ||Internal Medicine
|Fellowship||1995||The University of Chicago||Nephrology
Dr. Hammes studies end-stage renal failure and the effects long term dialysis has on the immune system. She also has an interest in vascular access and ways to monitor and prevent access thrombosis. Dr Hammes has been a participating investigator in several trials including Vitamin D analogs to suppress parathyroid hormone and Bactroban to prevent nasal carriage of staphylococcal bacteria in hemodialysis patients.
Comprehensive care of the end-stage renal failure patient with efforts to prevent complications as they pertain to hemodialysis and ensure adequate, safe, quality dialysis treatments.
- Hammes MS, Lieske JC, Pawar S, Spargo BH, Toback GF: Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney International 8: 501-509, 1995.
- Lieske JC, Hammes MS, Toback GF: Role of calcium oxalate monohydrate crystal interactions with renal epithelial cells in the pathogenesis of nephrolithiasis: a review. Scanning Microscopy 10: 519-534, 1996.
- Lieske JC, Hammes MS, Hoyer JR, Toback FG: Calcium oxalate monohydrate crystals stimulate gene expression and protein secretion in renal epithelial cells. Kidney International 51: 679-686, 1997.
- Poduval RD, Hammes MS. Tuberculosis screening in dialysis patients – is the tuberculin test effective? Clinical Nephrology 59: 436-440, 2003.
- Poduval RD, Wolgemuth C, Ferrell J, Hammes MS. Hyperphosphatemia in Dialysis: Is There a Role for Focused Counseling? Journal of Renal Nutrition 13: 219-223, 2003.